about
Killing a killer: what next for smallpox?Analysis of vaccinia virus-host protein-protein interactions: validations of yeast two-hybrid screeningsCytokine production associated with smallpox vaccine responsesStructural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responsesEvidence for Persistence of Ectromelia Virus in Inbred Mice, Recrudescence Following Immunosuppression and Transmission to Naïve MiceAdverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virusStructural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding proteinPotent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 ProteinEPIPOX: Immunoinformatic Characterization of the Shared T-Cell Epitome between Variola Virus and Related Pathogenic OrthopoxvirusesPoxviruses and the evolution of host range and virulenceComparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeysOrthopox Viruses: Infections in HumansImmune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected miceProteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination.Surviving mousepox infection requires the complement systemThe poxvirus A35 protein is an immunoregulatorMousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies.A novel highly reproducible and lethal nonhuman primate model for orthopox virus infectionVaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient miceFatal monkeypox in wild-living sooty mangabey, Côte d'Ivoire, 2012Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus.A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects.Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activityIdentification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models.Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virus.Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases.Poxvirus antigen staining of immune cells as a biomarker to predict disease outcome in monkeypox and cowpox virus infection in non-human primatesComparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route.Smallpox vaccines: targets of protective immunity.Comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (Mus musculus castaneus) and outbred African dormouse (Graphiurus kelleni).Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia virusesVennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone.Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus.Development of the small-molecule antiviral ST-246 as a smallpox therapeutic.An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodiesCowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox.Development of ST-246® for Treatment of Poxvirus Infections.Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics.
P2860
Q21131566-5C8C72D3-EF51-4799-BD33-2E19C0EEF68EQ24658402-57A031E9-C062-4BB5-9723-ACE37A905EFDQ26823501-D3946CB8-CA37-4BB0-A189-F3422689F99FQ26992101-A5A03F5F-6527-421D-A485-4D55C6F8B366Q27316583-F66182C7-A1E5-4D34-9559-4F5F4CA9A28DQ27346800-6052AE2E-D930-48E6-A314-987A090DC53CQ27653252-9B7FF8EC-5047-494C-9F52-BCABADEA66E0Q27684713-845D5DF2-9F61-45E0-B492-6BFBE289CA3DQ28607584-71DF4DB5-B733-4AA3-8DAE-1CFBCE64240FQ28658130-FF9DDC80-51E2-40DC-A59F-D0A8A561CB5CQ28741437-9686C9F5-19CA-4524-82D4-0D76ABDCC2C9Q28742218-F740421B-4E78-43BB-BE17-A8C72AF8D945Q28748570-D1F78F4B-09A7-4211-8B84-59C842BCCBCFQ30994031-F9FD44B1-2BB6-41AB-B785-AC766F8039BEQ33396210-7B969AB2-09DD-47FD-B059-B73ADF1A1381Q33558734-9646F190-5B12-4120-9E51-A2213C8AEF75Q33570349-AEAD752D-602F-4C1E-AB3C-689460CE9563Q33573571-E46117D0-DD54-42FD-ABD5-4ECCD301D607Q33632176-264B1118-82B8-452E-903C-A29A48CA941CQ33639966-71995E55-F9C4-4490-95C5-16071A0D921AQ33678645-03595945-4610-4D41-90E9-4BC962641C1DQ33700318-2980AAE9-744A-4A2A-AF32-B74B2873873AQ33769393-0ACC72A7-C3ED-4C70-AC41-59E4E0F32CD4Q33876688-DB29BEE3-AC61-450C-B187-8ADBB8D78FCDQ33972574-24F17C91-B0D2-422A-A20A-2CD5739F9D34Q34046006-8F5564A0-5887-4ACD-8A55-4CE9E71345D6Q34243476-CDC595A7-61CB-46EC-8A29-503A41DB813EQ34457869-592471E5-1ACB-445E-A8F3-225D244394ECQ34663791-E5C37A76-CAF9-470D-B6D5-F3F1882EDE9FQ34742139-EF4A56D4-0C8B-4C9D-88CA-94EEC8A291FDQ34780607-A4EE4C1B-06E8-4631-9F46-ADD0837F17B7Q34791242-A8620BBC-944F-4DFC-A6F2-1BED46B5BC76Q35023470-37E9BE74-08E6-4A8C-9C21-293ADA0F56F2Q35089019-E850231E-13D5-4313-8F92-CD64F620746BQ35110971-AE9F03D4-0BC4-49D6-B7BF-F82FFD2403EAQ35152092-54F6A7D6-37B0-4B0F-892D-E0C56BA2993CQ35186318-24AD4C63-DB82-45D1-81A4-6762100F8E36Q35189550-F04851D9-1809-4CBF-9FA2-E902158E2003Q35260385-34D80F42-E03B-4C11-AD50-70ED040EDE86Q35261304-58D98678-5D47-47D2-BD8C-126C62EA8A83
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Human monkeypox: an emerging zoonotic disease.
@en
type
label
Human monkeypox: an emerging zoonotic disease.
@en
prefLabel
Human monkeypox: an emerging zoonotic disease.
@en
P2093
P2860
P356
P1433
P1476
Human monkeypox: an emerging zoonotic disease.
@en
P2093
Anthony Nuara
Denise A Schultz
R Mark L Buller
Scott Parker
P2860
P356
10.2217/17460913.2.1.17
P577
2007-02-01T00:00:00Z